Results of high dose-rate brachytherapy boost before 2D or 3D external beam irradiation for prostate cancer

Radiotherapy and Oncology

Volumn 98, Issue 2, 2011, Pages 169-174

  Neviani, Cristiano Beck ^a   Miziara, Miguel Abrão ^a   De Andrade Carvalho, Heloisa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biochemical failure; Complications; High dose rate brachytherapy; Iridium radioisotopes therapeutical use; Prostate cancer; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SAFETY; TREATMENT FAILURE;

AGED; BRACHYTHERAPY; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES;

EID: 79951857495     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.01.005     Document Type: Article

References (42)

1. INCA. Brasil. Ministério da Saúde. Instituto Nacional do Câncer - INCA, Estimativa 2008. Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2010. http://www.inca.gov.br.
2. K. Shibuya, C.D. Mathers, C. Boschi-Pinto, A.D. Lopez, and C.J.L. Murray Correction: global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000 BMC Cancer 3 2003 20 Available at http://www.biomedcentral.com/1471-2407/3/20
3. M.J. Zelefsky, Z. Fuks, and M. Hunt High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J Urol 166 2001 876 881 (Pubitemid 32750970)
4. A. Pollack, G.K. Zagars, and G. Starkschall Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097 1105 (Pubitemid 34787842)
5. A. Pollack, A.L. Hanlon, E.M. Horwitz, S.J. Feigenberg, R.G. Uzzo, and G.E. Hanks Prostate cancer radiotherapy dose response: an update of the Fox Chase experience J Urol 171 2004 1132 1136 (Pubitemid 38327542)
6. D.P. Dearnaley, V.S. Khoo, and A.R. Norman Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial Lancet 353 1999 267 272 (Pubitemid 29088118)
7. T.P. Mate High dose-rate afterloading iridium-192 prostate brachytherapy: feasibility report Int J Radiat Oncol Biol Phys 41 1998 525 533 (Pubitemid 28275080)
8. D.G. Castro, A.C. Pellizzon, and M. Chen Avaliaão da resposta bioquímica no câncer inicial de próstata: experiência uninstitucional comparando teleterapia exclusiva ou associada braquiterapia de alta taxa de dose Radiol Bras 37 2004 265 269
9. A.C. Pellizzon, J.V. Salvajoli, and R.C. Fogaroli Conventional external beam radiation therapy and high dose rate afterloading brachytherapy as a boost for patients older than 70 years Appl Cancer Res Brazil 25 2005 130 136
10. A.C. Pellizzon, J. Salvajoli, and P. Novaes Updated results of high-dose rate brachytherapy and external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition Int Braz J Urol 34 2008 293 301
11. M. Sato, T. Mori, S. Shirai, K. Kishi, T. Inagaki, and I. Hara High-dose-rate brachytherapy of a single implant with two fractions combined with external beam radiotherapy for hormone-naive prostate cancer Int J Radiat Oncol Biol Phys 72 2008 1002 1009
12. F. Bachand, A.G. Martin, L. Beaulieu, F. Harel, and E. Vigneault An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome Int J Radiat Oncol Biol Phys 73 2009 679 684
13. J.E. Sylvester, J.C. Blasko, P.D. Grimm, R. Meier, and J.A. Malmgren Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience Int J Radiat Oncol Biol Phys 57 2003 944 952 (Pubitemid 37324111)
14. American Society for Therapeutic Radiology and Oncology American Society for Therapeutic Radiology and Oncology consensus panel consensus statement: guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 37 1997 1035 1041
15. M. Roach 3rd, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
16. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
17. R.G. Stock, J. Kao, and N.N. Stone Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer J Urol 165 2001 436 439 (Pubitemid 32060431)
18. R.G. Stock, N.N. Stone, and C. Iannuzzi Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer Int J Radiat Oncol Biol Phys 35 1996 267 272 (Pubitemid 26158747)
19. A.A. Martinez, J. Gonzales, and J.S. Stromberg Conformal prostate brachytherapy: initial experience of a phase I-II dose-escalating trial Int J Radiat Oncol Biol Phys 33 1995 1019 1027
20. G. Borghede, H. Hedelin, S. Holmäng, K.A. Johansson, G. Sernbo, and C. Mercke Combined treatment with temporary short-term high dose rate Iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma Radiother Oncol 44 1997 237 244 (Pubitemid 27405147)
21. S. Dinges, S. Deger, and S. Koswig High-dose-rate with external beam irradiation for localized prostate cancer-results of a prospective trial Radiother Oncol 48 1998 197 202 (Pubitemid 28423792)
22. T. Martin, S. Roddiger, and R. Kurek 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer Radiother Oncol 71 2004 35 41 (Pubitemid 38452900)
23. R.M. Galalae, A.A. Martinez, and T. Mate Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer Int J Radiat Oncol Biol Phys 58 2004 1048 1055 (Pubitemid 38314785)
24. L. Aström, D. Pedersen, C. Mercke, S. Holmäng, and K.A. Johansson Long-term outcome of high dose rate brachytherapy in radiotherapy of localized prostate cancer Radiother Oncol 74 2005 157 161 (Pubitemid 40331872)
25. S.M. Eulau, L. Van Hollebeke, and W. Cavanagh High dose rate iridium-192 brachytherapy in localized prostate cancer: Results and toxicity with maximum follow-up of 10 years [Abstract] Int J Radiat Oncol Biol Phys 48 2000 149
26. J.S. Stromberg, L. Kestin, and G. Gustafson Acute and late toxicity in men 70 years old treated with high dose rate brachytherapy boost and pelvic external irradiation for prostate cancer Int J Radiat Oncol Biol Phys 51 2001 308
27. J.S. Stromberg, A.A. Martinez, and L.L. Kestin Ultrasound guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I-II clinical trial Int J Radiat Oncol Biol Phys 33 1995 161 171
28. A.M.N. Syed, A. Puthawala, and A. Sharma High dose rate prostate brachytherapy in the treatment of carcinoma of the prostate Cancer Control 8 2001 511 521 (Pubitemid 34075931)
29. J. Hiratsuka, Y. Jo, K. Yoshida, N. Nagase, M. Fujisawa, and Y. Imajo Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer Int J Radiat Oncol Biol Phys 59 2004 684 690 (Pubitemid 38748733)
30. R.M. Galalae, G. Kovacs, and J. Schultze Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer Int J Radiat Oncol Biol Phys 52 2002 81 90 (Pubitemid 34044108)
31. D.J. Demanes, R.R. Rodriguez, L. Schour, D. Brandt, and G. Altieri High-dose-rate intensity modulated brachytherapy with external beam radiotherapy for prostate cancer: California Endocurietherapy's 10-year results Int J Radiat Oncol Biol Phys 61 2005 1306 1316 (Pubitemid 40470411)
32. L. Potters, T. Torre, P.A. Fearn, S.A. Leibel, and M.W. Kattan Potency after permanent prostate brachytherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 50 2001 1235 1242 (Pubitemid 32727801)
33. D.C. Weber, S. Bieri, J.M. Kurtz, and R. Miralbell Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer J Clin Oncol 17 1999 3444 3449 (Pubitemid 29517913)
34. M.J. Zelefsky, A.B. McKee, H. Lee, and S.A. Leibel Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate Urology 53 1999 775 778 (Pubitemid 29163044)
35. G.S. Merrick, W.M. Butler, J.H. Lief, R.L. Stipetich, L.J. Abel, and A.T. Dorsey Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction Urology 53 1999 1112 1116 (Pubitemid 29264738)
36. R.K. Valicenti, E. Choi, and C. Chen Sildenafil citrate effectively reverses sexual dysfunction induced by three-dimensional conformal radiation therapy Urology 57 2001 769 773
37. G.S. Merrick, W.M. Butler, and K.E. Wallner Erectile function after prostate brachytherapy Int J Radiat Oncol Biol Phys 62 2005 437 447 (Pubitemid 40704460)
38. R. Raina, A. Agarwal, and K.K. Goyal Long-term potency after iodine-125 radiotherapy for prostate cancer and role of sildenafil citrate Urology 62 2003 1103 1108 (Pubitemid 37510100)
39. D.J. Brenner, A.A. Martinez, G.K. Edmundson, C. Mitchell, H.D. Thames, and E.P. Armour Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β), similar to late-responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6 13 (Pubitemid 34041562)
40. J.Z. Wang, X.A. Li, C.X. Yu, and S.J. DiBiase The low α/β ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us? Int J Radiat Oncol Biol Phys 57 2003 1101 1108 (Pubitemid 37324129)
41. J. Fowler, R. Chappel, and M. Ritter Is α/β for prostate tumors really low? Int J Radiat Oncol Biol Phys 50 2001 1021 1031
42. C. King, and J. Fowler A simple analytic derivation suggests that prostate cancer α/β ratio is low Int J Radiat Oncol Biol Phys 51 2001 213 214 (Pubitemid 32758881)